Jonathan Duffy.

Eric S. Weintraub, M.P.H., James Baggs, Ph.D., Jonathan Duffy, M.D., M.P.H., Claudia Vellozzi, M.D., M.P.H., Edward A. Belongia, M.D., Stephanie Irving, M.H.S., Nicola P. Klein, M.D., Ph.D., Jason M. Glanz, Ph.D., Steven J. Jacobsen, M.D., Ph.D., Allison Naleway, Ph.D., Lisa A. Jackson, M.D., M.P.H., and Frank DeStefano, M.D., M.P.H.: Threat of Intussusception after Monovalent Rotavirus Vaccination The first licensed rotavirus vaccine was withdrawn from the U.S. Market in 1999 due to an increased threat of intussusception.1 Subsequently, two rotavirus vaccines have already been licensed in the United States: RotaTeq in 2006 and Rotarix in 2008.2,3 The two vaccines underwent prelicensure clinical trials involving 60,000 to 70,000 infants each, where no increased risk of intussusception was identified.4,5 Postlicensure monitoring in the Vaccine Safety Datalink project has not found an increase in the chance of intussusception after pentavalent rotavirus vaccination.6,7 At the time of the analysis of the pentavalent rotavirus vaccine, too few doses of the monovalent rotavirus vaccine have been administered to measure the risk of intussusception.This, in turn, boosts your confidence, as beautiful locks with a dash of glamour play a dynamic part in making you are feeling happy and boost your self esteem.. A&D Medical to partner with Salutron to expand Wellness Connected platform In a strategic business decision to supply its customers with an optimized connected health encounter, A&D Medical, a worldwide manufacturer of accuracy measurement solutions for the healthcare industry, announced today it’ll partner with Salutron, the industry innovator in wearable activity monitoring technology with heart rate.